Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMP warning letters issued by FDA in FY 1996 drop by 40% compared to previous year.

Executive Summary

GMP WARNING LETTERS SENT BY FDA DROP BY 40% IN FY 1996 compared to the number of letters issued during the agency's fiscal year 1995. Between October 1995 and September 1996, FDA issued 59 GMP warning letters to drug manufacturers, repackers and testing laboratories, compared with a total of over 100 in each of the previous two fiscal years (110 in 1995 and 100 in 1994).
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS029750

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel